CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Thyroid Cancer

 

If It Sounds Like a Duck, Is It a Quack?

By Melissa Young, MD | June 21, 2010

I don’t expect primary-care physicians and other subspecialists to know all the nuances of diagnosing and treating endocrine disorders. After all, that’s my job, right? If they could handle it all without me, I’d be looking for another line of work (although there are certainly days when that seems appealing).

But quite frequently, I am puzzled, and sometimes appalled, by what patients tell me their doctors did or said. Now granted, some of that may be the patient’s interpretation of what was said, but there are times when it is clear that a doctor consistently tells his/her patients the same thing. 

And what am I supposed to say when patients say, “My doctor told me it must be my thyroid,” especially when they come with a written request for consultation or a copy of a visit note that shows that, yes, indeed, their doctor does think it is their thyroid? And what am I supposed to say when their PCP increased their dose of levothyroxine based on their last labs. You know, the labs that showed that their thyroid hormone levels were too high already.

And what about the patient who was taking “Thyroid Pill”, conveniently purchased from her physician? I showed her the ingredients that I found on the practice website: calcium carbonate(Drug information on calcium carbonate), cellulose, gelatin, etc, etc. I didn’t say a word; I went about getting her history. She interrupted me midsentence, “There’s nothing in this!” OK, at least we were on the same page.

And what about the patient who wants human growth hormone because one of his doctors told him it would help increase his muscle mass? He even gave him a prescription. Only problem is his insurance won’t cover it unless his endocrinologist (i.e. me) sends a letter of medical necessity. Well, guess what, sunshine, that ain’t happening.

And what am I supposed to say about things I disagree with that aren’t in my specialty? Like the “Lyme specialist” who treats people for chronic Lyme disease with IV antibiotics for years. Or those diagnosed with chronic mono. Or patients who are getting vitamin B12 injections when their B12 levels are normal or even high?

When I think patients are in danger or if they are wasting their money, I tell them so. Sometimes they appreciate it, sometimes they dismiss my concerns. Whatever, they can’t say I didn’t tell them so.

I somehow feel partly responsible for letting these practitioners continue to do what they do, and there has been bad press about how docs protect other docs even when they are wrong. But what am I to do? Do I report them? To whom? For what? Boy, that would really make me popular in the physicians’ lounge, wouldn’t it?

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Medullary Thyroid Cancer in a 28-Year-Old Male
September 15, 2011
Cabozantinib Shows Promising Activity in Prostate Cancer Bone Metastases
August 24, 2011
Photosensitive Facial Rash Depicted Along with Polyarticular Arthralgias
April 29, 2011
Vandetanib Now Available to U.S. Patients with Advanced Medullary Thyroid Cancer
April 25, 2011
First Medullary Thyroid Cancer Drug is Approved
April 11, 2011
 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • Head and Neck Tumors
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


CancerNetwork on Facebook

 

 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Thyroid Cancer
Evidence on Thyroid Cancer
Guidelines on Thyroid Cancer
Patient Education on Thyroid Cancer
Clinical Trials on Thyroid Cancer
Practical Articles on Thyroid Cancer
Research and Reviews on Thyroid Cancer
All "Thyroid Cancer" results


CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy